185 related articles for article (PubMed ID: 18256112)
1. Forgiveness of non-adherence to HIV-1 antiretroviral therapy.
Shuter J
J Antimicrob Chemother; 2008 Apr; 61(4):769-73. PubMed ID: 18256112
[TBL] [Abstract][Full Text] [Related]
2. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
3. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
[TBL] [Abstract][Full Text] [Related]
4. "Solving the puzzle" of current HAART: what key strategic trials are needed?
Carosi G; Torti C
New Microbiol; 2004 Apr; 27(2 Suppl 1):127-30. PubMed ID: 15646075
[TBL] [Abstract][Full Text] [Related]
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
6. Strategies for improving patient adherence to therapy and long-term patient outcomes.
Battaglioli-DeNero AM
J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S17-22. PubMed ID: 17275718
[TBL] [Abstract][Full Text] [Related]
7. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
Taiwo B; Hicks C; Eron J
J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
[TBL] [Abstract][Full Text] [Related]
8. Optimal drug treatment regimens for HIV depend on adherence.
Krakovska O; Wahl LM
J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
Lagnese M; Daar ES
Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
[TBL] [Abstract][Full Text] [Related]
10. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
Wilson LE; Gallant JE
Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.
Sungkanuparph S; Anekthananon T; Hiransuthikul N; Bowonwatanuwong C; Supparatpinyo K; Mootsikapun P; Chetchotisakd P; Kiertiburanakul S; Tansuphaswadikul S; Buppanharun W; Manosuthi W; Techasathit W; Ratanasuwan W; Tantisiriwat W; Suwanagool S; Leechawengwongs M; Ruxrungtham K;
J Med Assoc Thai; 2008 Dec; 91(12):1925-35. PubMed ID: 19133532
[TBL] [Abstract][Full Text] [Related]
12. [AIDS treatment in Africa: the risk of antiretroviral resistance].
Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
[TBL] [Abstract][Full Text] [Related]
13. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
[TBL] [Abstract][Full Text] [Related]
15. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
[TBL] [Abstract][Full Text] [Related]
16. Improvements in antiretroviral therapy outcomes over calendar time.
Boyd MA
Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
[TBL] [Abstract][Full Text] [Related]
17. Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.
Lima VD; Gill VS; Yip B; Hogg RS; Montaner JS; Harrigan PR
J Infect Dis; 2008 Jul; 198(1):51-8. PubMed ID: 18498238
[TBL] [Abstract][Full Text] [Related]
18. Adherence to antiretroviral therapy: how much is enough?
Gulick RM
Clin Infect Dis; 2006 Oct; 43(7):942-4. PubMed ID: 16941381
[No Abstract] [Full Text] [Related]
19. Levels of adherence required for virologic suppression among newer antiretroviral medications.
Kobin AB; Sheth NU
Ann Pharmacother; 2011 Mar; 45(3):372-9. PubMed ID: 21386024
[TBL] [Abstract][Full Text] [Related]
20. When to start antiretroviral therapy: a swinging pendulum?
Gallant JE
Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]